TVTX: Travere Therapeutics, Inc.
2021-12-15 07:00:00
Travere Therapeutics Announces Positive Topline Results from the Ongoing Phase 1/2 COMPOSE Study of Pegtibatinase in Classical Homocystinuria
Pupm&Dump trading strategy idea.
$TVTX is rising too much today.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price today.
So I opened a short position from $19,00;
stop-loss — $20,50;
take-profit — $16,02/MOC
Do not view this idea as a recommendation for trading or investing. It is...